Impact of the Novel 5-Group Cytogenetic Risk Classification of MDS on Outcome After Allogeneic Hematopoietic Cell Transplantation (HCT)

被引：3
|
作者：
Deeg, H. Joachim [1 ]
Scott, Bart Lee [1 ,2 ]
Appelbaum, Frederick R. [1 ]
Gooley, Ted [1 ]
机构：
[1] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA
[2] Univ Washington, Seattle, WA 98195 USA
来源：
BLOOD | 2011年 / 118卷 / 21期
关键词：
D O I：
10.1182/blood.V118.21.666.666
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：306 / 307
页数：2
相关论文
共 50 条
  • [21] Impact of Gut Fungal Composition on Outcome after Allogeneic Hematopoietic Cell Transplantation
    Malard, Florent
    Lavelle, Aonghus
    Battipaglia, Giorgia
    Gaugler, Beatrice
    Dulery, Remy
    Brissot, Eolia
    Ledraa, Tounes
    Mohty, Razan
    Sokol, Harry
    Mohty, Mohamad
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 318 - 319
  • [22] Impact of Cytogenetics on Outcome of AML after Allogeneic Hematopoietic Stem Cell Transplantation
    Gindina, Tatiana L.
    Mamaev, Nikolay N.
    Afanasyev, Boris V.
    Bondarenko, Sergey N.
    Alyanskiy, Alexander
    Slesarchuk, Olga
    Moiseev, Ivan S.
    Razumova, Svetlana V.
    Zubarovskaya, Lyudmila
    BLOOD, 2015, 126 (23)
  • [23] Pre-transplant 5-azacitidine (Vidaza®) may improve outcome of allogeneic hematopoietic cell transplantation (HCT) in patients with myelodysplastic syndrome (MDS).
    Field, Teresa
    Perkins, Janelle
    Alsina, Melissa
    Ayala, Ernesto
    Fernandez, Hugo F.
    Janssen, William
    Kharfan-Dabaja, Mohamed
    Lancet, Jeffery
    Perez, Lia
    Sullivan, Daniel
    List, Alan
    Anasetti, Claudio
    BLOOD, 2006, 108 (11) : 1047A - 1047A
  • [24] RISK SCORE FOR OUTCOME AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN CHILDHOOD
    Arndt, C.
    Wolff, I.
    Beck, J. F.
    Gruhn, B.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S275 - S276
  • [25] Azacitidine maintenance after allogeneic hematopoietic cell transplantation for MDS and AML
    El Chaer, Firas
    Borate, Uma
    Dulery, Remy
    Holtan, Shernan G.
    Law, Arjun Datt
    Muffly, Lori
    Nassereddine, Samah
    Shallis, Rory M.
    Stringaris, Kate
    Taylor, Justin
    Devine, Steven M.
    Mohty, Mohamad
    Hourigan, Christopher S.
    BLOOD ADVANCES, 2021, 5 (06) : 1757 - 1759
  • [26] Outcome after Hematopoietic Stem Cell Transplantation for Pediatric MDS
    Park, J. A.
    Lim, Y. J.
    Koh, K-N
    Seo, J. J.
    Im, H. J.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S253 - S254
  • [27] Spleen Status and Engraftment After Allogeneic Hematopoietic Stem Cell Transplantation (HCT)
    Akpek, Gorgun
    Pasquini, Marcelo C.
    Agovi, Manza-A
    Logan, Brent
    Cooke, Kenneth R.
    Maziarz, Richard T.
    Gupta, Vikas
    Lazarus, Hillard M.
    Hale, Gregory A.
    Marks, David I.
    Maharaj, Dipnarine
    Popat, Uday
    Carabasi, Matthew
    Bornhaeuser, Martin
    Bolwell, Brian J.
    Ringden, Olle
    Ballen, Karen K.
    Rizzo, J. Douglas
    McCarthy, Philip L.
    Ho, Vincent T.
    BLOOD, 2010, 116 (21) : 1432 - 1433
  • [28] Mixed Chimerism after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with β Thalassemia: Impact on Outcome and Risk Factors
    Tan, Wanxia
    He, Yuelin
    Feng, Xiaoqin
    Wu, Xuedong
    Li, Chunfu
    Liao, Jianyun
    Liu, Huaying
    Liu, Xuan
    Pei, Fuyu
    Liu, Qiujun
    Liu, Xiaoting
    Ren, Yuqiong
    BLOOD, 2020, 136
  • [29] Impact of Donor Type on Outcome after Allogeneic Hematopoietic Cell Transplantation for Acute Leukemia
    Solomon, Scott R.
    Sizemore, Connie A.
    Zhang, Xu
    Brown, Stacey
    Holland, H. Kent
    Morris, Lawrence E.
    Solh, Melhem
    Bashey, Asad
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (10) : 1816 - 1822
  • [30] Risk Score for Outcome After Allogeneic Hematopoietic Stem Cell Transplantation A Retrospective Analysis
    Gratwohl, Alois
    Stern, Martin
    Brand, Ronald
    Apperley, Jane
    Baldomero, Helen
    de Witte, Theo
    Dini, Giorgio
    Rocha, Vanderson
    Passweg, Jakob
    Sureda, Anna
    Tichelli, Andre
    Niederwieser, Dietger
    CANCER, 2009, 115 (20) : 4715 - 4726
12345